12/25
08:51 am
gmab
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at Sanford C. Bernstein from a "strong sell" rating to a "hold" rating.
Low
Report
Genmab A/S (NASDAQ: GMAB) was upgraded by analysts at Sanford C. Bernstein from a "strong sell" rating to a "hold" rating.
12/20
06:30 am
gmab
Genmab upgraded to Market Perform from Underperform at Bernstein
Low
Report
Genmab upgraded to Market Perform from Underperform at Bernstein
12/20
06:30 am
gmab
Genmab upgraded to Market Perform from Underperform at Bernstein
Low
Report
Genmab upgraded to Market Perform from Underperform at Bernstein
11/8
10:34 am
gmab
Genmab A/S (NASDAQ: GMAB) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, up previously from $46.00.
Low
Report
Genmab A/S (NASDAQ: GMAB) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, up previously from $46.00.
11/8
10:29 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
11/8
10:29 am
gmab
Rating for GMAB
Low
Report
Rating for GMAB
10/16
08:31 am
gmab
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Low
Report
Genmab A/S (NASDAQ: GMAB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.